Elutia Inc. (ELUT)
NASDAQ: ELUT · IEX Real-Time Price · USD
4.000
-0.010 (-0.25%)
At close: Jul 19, 2024, 4:30 PM
4.040
+0.040 (1.00%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Elutia Revenue
Elutia had revenue of $28.99M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $6.69M with 4.72% year-over-year growth. In the year 2023, Elutia had annual revenue of $24.75M with 3.76% growth.
Revenue (ttm)
$28.99M
Revenue Growth
-7.86%
P/S Ratio
3.80
Revenue / Employee
$536,889
Employees
54
Market Cap
110.10M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 24.75M | 896.00K | 3.76% |
| Dec 31, 2022 | 23.85M | -23.54M | -49.68% |
| Dec 31, 2021 | 47.39M | 4.71M | 11.03% |
| Dec 31, 2020 | 42.68M | -219.00K | -0.51% |
| Dec 31, 2019 | 42.90M | 3.86M | 9.90% |
| Dec 31, 2018 | 39.04M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 140.46M |
| CytomX Therapeutics | 119.18M |
| Journey Medical | 80.00M |
| Augmedix | 48.70M |
| BrainsWay | 34.26M |
| Adagene | 18.11M |
| Armata Pharmaceuticals | 4.70M |
| I-Mab | 3.90M |
ELUT News
- 10 days ago - Elutia to Present at the Emerging Growth Conference on Thursday, July 18 - GlobeNewsWire
- 4 weeks ago - Elutia Announces $13.26 Million Registered Direct Offering - GlobeNewsWire
- 4 weeks ago - Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators - GlobeNewsWire
- 3 months ago - Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1 - GlobeNewsWire
- 4 months ago - Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024 - GlobeNewsWire
- 5 months ago - Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024 - GlobeNewsWire
- 6 months ago - Elutia Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 8 months ago - Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results - GlobeNewsWire